DESTIN, Fla., July 13 /PRNewswire-FirstCall/ -- Concordis
Group, Inc. (Pink Sheets: CNGI), a growing financial holding
company, today announced the development of a new captive insurance
cell targeting the excessive medical costs experienced by
mid-market companies.
This new cell will be marketed to small-to-medium size
businesses that are looking for ways to control their escalating
health care costs.
Trent Sommerville, CEO of
Concordis Group, Inc. stated, "Most small-to-medium size businesses
today are very concerned about new government regulations regarding
health care and how it affects their business. The program's
structure is designed to allow our clients to better control these
costs which ultimately impact their bottom line."
This cell is expected to be launched by the 4th quarter
2010.
About Concordis Group, Inc.
Concordis Group, Inc. is a diversified holding company that
provides business insurance solutions through its two wholly own
subsidiaries: Concordis Insurance SPC (CISPC) and Concordis
Capital, Inc.(CCI). CISPC, a Cayman Island corporation, is a
captive insurance company that specializes in structuring and
managing alternative risk management solutions for mid-market
companies. CCI, a Florida
corporation, provides captive cell funding for CISPC and other
businesses and organizations.
Concordis Group's business strategy is based upon strong organic
growth combined with strategic acquisitions of companies in the
financial services and insurance industries that create additional
synergy, have positive cash-flow, exhibit strong long-term growth
potential, and have highly qualified management teams.
SOURCE Concordis Group, Inc.